{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:21:28Z","timestamp":1789777288646,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["82171726"],"award-info":[{"award-number":["82171726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["81471580"],"award-info":[{"award-number":["81471580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["82270232"],"award-info":[{"award-number":["82270232"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pengcheng Excellence--Medical Key Talents Cultivation Project","award":["XWRCHT20220068"],"award-info":[{"award-number":["XWRCHT20220068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03752-6","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T16:22:29Z","timestamp":1731082949000},"page":"2579-2596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrated analysis of single-cell and bulk RNA-sequencing identifies a metastasis-related gene signature for predicting prognosis in lung adenocarcinoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Xu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2463-8933","authenticated-orcid":false,"given":"Zhengxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"10","key":"3752_CR1","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","volume":"28","author":"MB Schabath","year":"2019","unstructured":"Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1563\u201379. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0221.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"16","key":"3752_CR2","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.3390\/ijms22168661","volume":"22","author":"R Nooreldeen","year":"2021","unstructured":"Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci. 2021;22(16):8661. https:\/\/doi.org\/10.3390\/ijms22168661.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3752_CR3","first-page":"5","volume":"110","author":"E Kuhn","year":"2018","unstructured":"Kuhn E, Morbini P, Cancellieri A, Damiani S, Cavazza A, Comin CE. Adenocarcinoma classification: patterns and prognosis. Pathologica. 2018;110(1):5\u201311.","journal-title":"Pathologica"},{"issue":"10","key":"3752_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41571-023-00794-7","volume":"20","author":"G Mountzios","year":"2023","unstructured":"Mountzios G, Remon J, Hendriks LEL, Garc\u00eda-Campelo R, Rolfo C, Van Schil P, et al. Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges. Nat Rev Clin Oncol. 2023;20(10):664\u201377. https:\/\/doi.org\/10.1038\/s41571-023-00794-7.","journal-title":"Nat Rev Clin Oncol"},{"issue":"162","key":"3752_CR5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0045-2021","volume":"30","author":"PR Benusiglio","year":"2021","unstructured":"Benusiglio PR, Fallet V, Sanchis-Borja M, Coulet F, Cadranel J. Lung cancer is also a hereditary disease. Eur Respir Rev. 2021;30(162): 210045. https:\/\/doi.org\/10.1183\/16000617.0045-2021.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"3752_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/ijms19041259","volume":"19","author":"K Inamura","year":"2018","unstructured":"Inamura K. Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression. Int J Mol Sci. 2018;19(4):1259. https:\/\/doi.org\/10.3390\/ijms19041259.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3752_CR7","doi-asserted-by":"publisher","first-page":"1601734","DOI":"10.1183\/13993003.01734-2016","volume":"49","author":"O Calvayrac","year":"2017","unstructured":"Calvayrac O, Pradines A, Pons E, Mazi\u00e8res J, Guibert N. Molecular biomarkers for lung adenocarcinoma. Eur Respir J. 2017;49(4):1601734. https:\/\/doi.org\/10.1183\/13993003.01734-2016.","journal-title":"Eur Respir J"},{"issue":"1","key":"3752_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, et al. Single-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021;40(1):81. https:\/\/doi.org\/10.1186\/s13046-021-01874-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3752_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18(1):35\u201345. https:\/\/doi.org\/10.1038\/nri.2017.76.","journal-title":"Nat Rev Immunol"},{"key":"3752_CR10","doi-asserted-by":"publisher","first-page":"175883592312102","DOI":"10.1177\/17588359231210274","volume":"16","author":"L Song","year":"2024","unstructured":"Song L, Gong Y, Wang E, Huang J, Li Y. Unraveling the tumor immune microenvironment of lung adenocarcinoma using single-cell RNA sequencing. Ther Adv Med Oncol. 2024;16:17588359231210274. https:\/\/doi.org\/10.1177\/17588359231210274.","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"3752_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41591-019-0750-6","volume":"26","author":"AM Laughney","year":"2020","unstructured":"Laughney AM, Hu J, Campbell NR, Bakhoum SF, Setty M, Lavall\u00e9e V-P, et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat Med. 2020;26(2):259\u201369. https:\/\/doi.org\/10.1038\/s41591-019-0750-6.","journal-title":"Nat Med"},{"issue":"1","key":"3752_CR12","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1.","journal-title":"Nat Commun"},{"issue":"186","key":"3752_CR13","doi-asserted-by":"publisher","first-page":"186ra66","DOI":"10.1126\/scitranslmed.3005723","volume":"5","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux S, Debernardi A, Jacquiau B, Vitte A-L, Vesin A, Nagy-Mignotte H, et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5(186):186ra66. https:\/\/doi.org\/10.1126\/scitranslmed.3005723.","journal-title":"Sci Transl Med."},{"issue":"1","key":"3752_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","volume":"72","author":"H Okayama","year":"2012","unstructured":"Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, et al. Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas. Cancer Res. 2012;72(1):100\u201311. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1403.","journal-title":"Cancer Res"},{"issue":"1","key":"3752_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1078-0432.CCR-12-1139","volume":"19","author":"J Botling","year":"2013","unstructured":"Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M, et al. Biomarker discovery in non-small cell lung cancer: integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res. 2013;19(1):194\u2013204. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3752_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","volume":"9","author":"SD Der","year":"2014","unstructured":"Der SD, Sykes J, Pintilie M, Zhu C-Q, Strumpf D, Liu Ni, et al. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J Thorac Oncol. 2014;9(1):59\u201364. https:\/\/doi.org\/10.1097\/JTO.0000000000000042.","journal-title":"J Thorac Oncol"},{"issue":"25","key":"3752_CR17","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan S, Winter PS, Navia AW, Williams HL, DenAdel A, Lowder KE, et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell. 2021;184(25):6119-6137.e26. https:\/\/doi.org\/10.1016\/j.cell.2021.11.017.","journal-title":"Cell"},{"key":"3752_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.omtn.2023.06.001","volume":"33","author":"G Chu","year":"2023","unstructured":"Chu G, Ji X, Wang Y, Niu H. Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer. Mol Ther Nucleic Acids. 2023;33:110\u201326. https:\/\/doi.org\/10.1016\/j.omtn.2023.06.001.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"3752_CR19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Hui X, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6.","journal-title":"Nat Commun"},{"key":"3752_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106597","volume":"154","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhu H, Wang X, Lin S, Ruan C, Wang Q. A novel basement membrane-related gene signature for prognosis of lung adenocarcinomas. Comput Biol Med. 2023;154: 106597. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106597.","journal-title":"Comput Biol Med"},{"key":"3752_CR21","doi-asserted-by":"publisher","first-page":"1323344","DOI":"10.3389\/fmed.2023.1323344","volume":"10","author":"H Jiang","year":"2023","unstructured":"Jiang H, Bu L. Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine. Front Med (Lausanne). 2023;10:1323344. https:\/\/doi.org\/10.3389\/fmed.2023.1323344.","journal-title":"Front Med (Lausanne)"},{"issue":"1\u20132","key":"3752_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000487440","volume":"85","author":"VML de Sousa","year":"2018","unstructured":"de Sousa VML, Carvalho L. Heterogeneity in lung cancer. Pathobiology. 2018;85(1\u20132):96\u2013107. https:\/\/doi.org\/10.1159\/000487440.","journal-title":"Pathobiology"},{"issue":"20","key":"3752_CR23","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920\u201330. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.001593.","journal-title":"Circulation"},{"issue":"13","key":"3752_CR24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug CJ, Drazen JM. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. 2023;388(13):1201\u20138. https:\/\/doi.org\/10.1056\/NEJMra2302038.","journal-title":"N Engl J Med"},{"key":"3752_CR25","doi-asserted-by":"publisher","first-page":"677169","DOI":"10.3389\/fimmu.2021.677169","volume":"12","author":"L Liu","year":"2021","unstructured":"Liu L, Wang C, Li S, Qu Y, Xue P, Ma Z, et al. ERO1L is a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment. Front Immunol. 2021;12:677169. https:\/\/doi.org\/10.3389\/fimmu.2021.677169.","journal-title":"Front Immunol"},{"issue":"12","key":"3752_CR26","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/cbin.11454","volume":"44","author":"X Shi","year":"2020","unstructured":"Shi X, Wu J, Liu Y, Jiang Y, Zhi C, Li J. ERO1L promotes NSCLC development by modulating cell cycle-related molecules. Cell Biol Int. 2020;44(12):2473\u201384. https:\/\/doi.org\/10.1002\/cbin.11454.","journal-title":"Cell Biol Int"},{"issue":"10","key":"3752_CR27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/mc.23441","volume":"61","author":"J Xie","year":"2022","unstructured":"Xie J, Liao G, Feng Z, Liu B, Li X, Qiu M. ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2\/\u03b2-catenin signaling pathway. Mol Carcinog. 2022;61(10):897\u2013909. https:\/\/doi.org\/10.1002\/mc.23441.","journal-title":"Mol Carcinog"},{"key":"3752_CR28","doi-asserted-by":"publisher","first-page":"1560199","DOI":"10.1155\/2022\/1560199","volume":"2022","author":"H Wang","year":"2022","unstructured":"Wang H, Wang X, Xu L, Lin Y, Zhang J. CCT6A and CHCHD2 Are coamplified with EGFR and associated with the unfavorable clinical outcomes of lung adenocarcinoma. Dis Markers. 2022;2022:1560199. https:\/\/doi.org\/10.1155\/2022\/1560199.","journal-title":"Dis Markers"},{"issue":"1","key":"3752_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12957-020-01911-x","volume":"18","author":"T Zhang","year":"2020","unstructured":"Zhang T, Shi W, Tian K, Kong Y. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma. World J Surg Oncol. 2020;18(1):156. https:\/\/doi.org\/10.1186\/s12957-020-01911-x.","journal-title":"World J Surg Oncol"},{"issue":"2","key":"3752_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/metabo13020142","volume":"13","author":"X Ouyang","year":"2023","unstructured":"Ouyang X, Zhu R, Lin L, Wang X, Zhuang Q, Hu D. GAPDH Is a novel ferroptosis-related marker and correlates with immune microenvironment in lung adenocarcinoma. Metabolites. 2023;13(2):142. https:\/\/doi.org\/10.3390\/metabo13020142.","journal-title":"Metabolites"},{"issue":"1","key":"3752_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2353\/ajpath.2006.050291","volume":"168","author":"E Zudaire","year":"2006","unstructured":"Zudaire E, Mart\u00ednez A, Garayoa M, P\u00edo R, Kaur G, Woolhiser MR, et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol. 2006;168(1):280\u201391. https:\/\/doi.org\/10.2353\/ajpath.2006.050291.","journal-title":"Am J Pathol"},{"key":"3752_CR32","doi-asserted-by":"publisher","first-page":"694071","DOI":"10.3389\/fcell.2021.694071","volume":"9","author":"D Che","year":"2021","unstructured":"Che D, Wang M, Sun J, Li B, Xu T, Lu Y, et al. KRT6A promotes lung cancer cell growth and invasion through myc-regulated pentose phosphate pathway. Front Cell Dev Biol. 2021;9:694071. https:\/\/doi.org\/10.3389\/fcell.2021.694071.","journal-title":"Front Cell Dev Biol."},{"key":"3752_CR33","doi-asserted-by":"publisher","first-page":"153303382092124","DOI":"10.1177\/1533033820921248","volume":"19","author":"B Yang","year":"2020","unstructured":"Yang B, Zhang W, Zhang M, Wang X, Peng S, Zhang R. KRT6A promotes EMT and cancer stem cell transformation in lung adenocarcinoma. Technol Cancer Res Treat. 2020;19:1533033820921248. https:\/\/doi.org\/10.1177\/1533033820921248.","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"3752_CR34","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1007\/s13277-014-1674-x","volume":"35","author":"CH Xu","year":"2014","unstructured":"Xu CH, Zhang Y, Yu LK. The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer. Tumour Biol. 2014;35(6):5199\u2013203. https:\/\/doi.org\/10.1007\/s13277-014-1674-x.","journal-title":"Tumour Biol"},{"issue":"7","key":"3752_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41594-023-00985-x","volume":"30","author":"Q Chen","year":"2023","unstructured":"Chen Q, Menon RP, Masino L, Tolar P, Rosenthal PB. Structural basis for Fc receptor recognition of immunoglobulin M. Nat Struct Mol Biol. 2023;30(7):1033\u20139. https:\/\/doi.org\/10.1038\/s41594-023-00985-x.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"3752_CR36","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1134\/S0026893307040115","volume":"41","author":"DK Slizhikova","year":"2007","unstructured":"Slizhikova DK, Zinovyeva MV, Kuzmin DV, Snezhkov EV, Shakhparonov MI, Dmitriev RI, et al. Decrease in expression of human J-chain in lung squamous cell cancer and adenocarcinoma. Mol Biol (Mosk). 2007;41(4):659\u201365.","journal-title":"Mol Biol (Mosk)"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03752-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T14:16:59Z","timestamp":1747405019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03752-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["3752"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03752-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}